KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Inventory (2016 - 2025)

Historic Inventory for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $8.2 million.

  • Chemed's Inventory fell 1677.95% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year decrease of 1677.95%. This contributed to the annual value of $8.2 million for FY2024, which is 3174.78% down from last year.
  • Latest data reveals that Chemed reported Inventory of $8.2 million as of Q3 2025, which was down 1677.95% from $9.1 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Inventory ranged from a high of $12.5 million in Q3 2023 and a low of $6.8 million during Q1 2021
  • Over the past 5 years, Chemed's median Inventory value was $10.3 million (recorded in 2022), while the average stood at $9.8 million.
  • In the last 5 years, Chemed's Inventory surged by 5552.6% in 2022 and then tumbled by 3174.78% in 2024.
  • Quarter analysis of 5 years shows Chemed's Inventory stood at $10.1 million in 2021, then grew by 1.61% to $10.3 million in 2022, then grew by 16.86% to $12.0 million in 2023, then tumbled by 31.75% to $8.2 million in 2024, then grew by 0.55% to $8.2 million in 2025.
  • Its Inventory stands at $8.2 million for Q3 2025, versus $9.1 million for Q2 2025 and $7.8 million for Q1 2025.